The role of chest X-ray in the early diagnosis and staging of sarcoidosis: Is it really should be done?

BACKGROUND: Sarcoidosis is a chronic granulomatous disease characterized by non-caseating granuloma. The conventional chest X-ray (CXR) has important role in the diagnosis, staging and follow-up of disease. Computed tomography (CT) is a second-line imaging method used to determine the extent, complications and differential diagnosis of sarcoidosis. OBJECTIVES: To determine the role of CXR in the early diagnosis and staging of sarcoidosis and to compare with CT imaging. METHODS: One hundred and nine sarcoidosis patients followed at a single center were included in the study. Demographic, radiological, and clinical data of 81 patients were obtained from a total of 109 patients, and the record data of these 81 patients were evaluated. Patients who could not be reached for all tests were excluded from the study. CXR and CT imaging taken at diagnosis were evaluated retrospectively independently from two radiologists and one rheumatologist. RESULTS: Among 109 patients, eighty-one patients CXR and CT imaging taken at the same center has been reached. Among 81 sarcoidosis patients 23 (28.4%) were male, 58 (71.6%) were female. The mean patients age was 46.4 years and the mean disease duration was 3.8 years. CXR is regarded as normal at diagnosis in 30 patients (37%), while all of these patients had findings consistent with sarcoidosis on CT imaging. CT imaging are more superior than CXR in the early diagnosis and staging of sarcoidosis (p=0.001). Also CT imaging is more superior for detection of disease extent and complications. CONCLUSIONS: In this study, we observed that CT imaging outperforms CXR in terms of early detection and staging of sarcoidosis. The use of CT imaging is important for early diagnosis and staging of sarcoidosis. The low performance of CXR is a condition that requires the discussion of this method. Multicenter prospective study is needed in this regard.

The role of chest X-ray in the early diagnosis and staging of sarcoidosis: Is it really should be done? / El papel de la radiografía de tórax en el diagnóstico precoz y estadificación de la sarcoidosis: ¿realmente se debe hacer?

Background: Sarcoidosis is a chronic granulomatous disease characterized by non-caseating granuloma. The conventional chest X-ray (CXR) has important role in the diagnosis, staging and follow-up of disease. Computed tomography (CT) is a second-line imaging method used to determine the extent, complications and differential diagnosis of sarcoidosis. Objectives: To determine the role of CXR in the early diagnosis and staging of sarcoidosis and to compare with CT imaging. Methods: One hundred and nine sarcoidosis patients followed at a single center were included in the study. Demographic, radiological, and clinical data of 81 patients were obtained from a total of 109 patients, and the record data of these 81 patients were evaluated. Patients who could not be reached for all tests were excluded from the study. CXR and CT imaging taken at diagnosis were evaluated retrospectively independently from two radiologists and one rheumatologist. Results: Among 109 patients, eighty-one patients CXR and CT imaging taken at the same center has been reached. Among 81 sarcoidosis patients 23 (28.4%) were male, 58 (71.6%) were female. The mean patients age was 46.4 years and the mean disease duration was 3.8 years. CXR is regarded as normal at diagnosis in 30 patients (37%), while all of these patients had findings consistent with sarcoidosis on CT imaging. CT imaging are more superior than CXR in the early diagnosis and staging of sarcoidosis (p=0.001). Also CT imaging is more superior for detection of disease extent and complications. Conclusions: In this study, we observed that CT imaging outperforms CXR in terms of early detection and staging of sarcoidosis. The use of CT imaging is important for early diagnosis and staging of sarcoidosis. The low performance of CXR is a condition that requires the discussion of this method. Multicenter prospective study is needed in this regard.(AU)

Antecedentes: La sarcoidosis es una enfermedad granulomatosa crónica caracterizada por un granuloma no caseificante. La radiografía de tórax convencional (CXR) tiene un papel importante en el diagnóstico, estadificación y seguimiento de la enfermedad. La tomografía computarizada (TC) es un método de imagen de segunda línea que se utiliza para determinar la extensión, las complicaciones y el diagnóstico diferencial de la sarcoidosis. Objetivos: Determinar el papel de la radiografía de tórax en el diagnóstico temprano y la estadificación de la sarcoidosis y compararlo con la tomografía computarizada. Métodos: Se incluyeron en el estudio 109 pacientes con sarcoidosis seguidos en un solo centro. Se obtuvieron datos demográficos, radiológicos y clínicos de 81 sujetos de un total de 109 pacientes, y se evaluaron los datos de registro de estos 81 individuos. Los pacientes que no pudieron ser contactados para todas las pruebas fueron excluidos del estudio. Las imágenes de CXR y CT tomadas en el momento del diagnóstico fueron evaluadas retrospectivamente de forma independiente por 2 radiólogos y un reumatólogo. Resultados: De un total de 109 pacientes se han obtenido imágenes de CXR y CT, tomadas en el mismo centro, de 81 individuos. De esos 81 pacientes con sarcoidosis 23 (28,4%) eran hombres y 58 (71,6%) eran mujeres. La edad media de los pacientes fue de 46,4 años y la duración media de la enfermedad fue de 3,8 años. La CXR se considera normal en el momento del diagnóstico en 30 pacientes (37%), mientras que todos estos pacientes tenían hallazgos consistentes con sarcoidosis en la TC. La TC es superior a la radiografía de tórax en el diagnóstico temprano y la estadificación de la sarcoidosis (p=0,001) y en la detección de la extensión de la enfermedad y las complicaciones. Conclusiones: En este estudio observamos que la TC supera a la radiografía de tórax en términos de detección temprana y estadificación de la sarcoidosis...(AU)

Does the Thymus Index Predict COVID-19 Severity?

BACKGROUND: The COVID-19 (coronavirus disease 2019) pandemic is a global health emergency that is straining health care resources. Identifying patients likely to experience severe illness would allow more targeted use of resources. This study aimed to investigate the association between the thymus index (TI) on thorax computed tomography (CT) and prognosis in patients with COVID-19. METHODS: A multicenter, cross-sectional, retrospective study was conducted between March 17 and June 30, 2020, in patients with confirmed COVID-19. The patients' clinical history and laboratory data were collected after receiving a signed consent form. Four experienced radiologists who were blinded to each other and patient data performed image evaluation. The appearance of the thymus was assessed in each patient using 2 published systems, including the TI and thymic morphology. Exclusion criteria were lack of initial diagnostic thoracic CT, previous sternotomy, pregnancy, and inappropriate images for thymic evaluation. A total of 2588 patients with confirmed COVID-19 and 1231 of these with appropriate thoracic CT imaging were included. Multivariable analysis was performed to predict the risk of severe disease and mortality. RESULTS: The median age was 45 (interquartile range, 33-58) years; 52.2% were male. Two hundred forty-nine (20.2%) patients had severe disease, and 60 (4.9%) patients died. Thymus index was significantly associated with mortality and severe disease (odds ratios, 0.289 [95% confidence interval, 0.141-0.588; P = 0.001]; and 0.266 [95% confidence interval, 0.075-0.932; P = 0.038]), respectively. Perithymic lymphadenopathy on CT imaging had a significantly strong association with grades of TI in patients with severe disease and death ( V = 0.413 P = 0.017; and V = 0.261 P = 0.002, respectively). A morphologically assessable thymus increased the probability of survival by 17-fold and the absence of severe disease by 12-fold. CONCLUSION: Assessment of the thymus in patients with COVID-19 may provide useful prognostic data for both disease severity and mortality.

Usefulness of laboratory parameters and chest CT in the early diagnosis of COVID-19.

In the present study, the importance of laboratory parameters and CT findings in the early diagnosis of COVID-19 was investigated. To this end, 245 patients admitted between April 1st, and May 30th, 2020 with suspected COVID-19 were enrolled. The patients were divided into three groups according to chest CT findings and RT-PCR results. The non-COVID-19 group consisted of 71 patients with negative RT-PCR results and no chest CT findings. Ninety-five patients with positive RT-PCR results and negativechest CT findings were included in the COVID-19 group; 79 patients with positive RT-PCR results and chest CT findings consistent with COVID-19 manifestations were included in COVID-19 pneumonia group. Chest CT findings were positive in 45% of all COVID-19 patients. Patients with positive chest CT findings had mild (n=30), moderate (n=21) andor severe (n=28) lung involvement. In the COVID-19 group, CRP levels and the percentage of monocytes increased significantly. As disease progressed from mild to severe, CRP, LDH and ferritin levels gradually increased. In the ROC analysis, the area under the curve corresponding to the percentage value of monocytes (AUC=0.887) had a very good accuracy in predicting COVID-19 cases. The multinomial logistic regression analysis showed that CRP, LYM and % MONO were independent factors for COVID-19. Furthermore, the chest CT evaluation is a relevant tool in patients with clinical suspicion of COVID-19 pneumonia and negative RT-PCR results. In addition to decreased lymphocyte count, the increased percentage of monocytes may also guide the diagnosis.

The prevalence and extent of coronary atherosclerosis among patients with a zero calcium score and the influence of patient characteristics.

PURPOSE: Coronary artery calcium (CAC) is a specific indicator of and an independent risk factor for atherosclerosis; however, calcium scoring may miss noncalcified plaques, which may have clinical importance. The aim of this study was both to identify the presence and extent of coronary plaques during computed tomography coronary angiography (CTCA) in patients with a zero CAC score and to evaluate the effect of risk factors and symptom status on the presence of noncalcified plaques. MATERIALS AND METHODS: In this retrospective study, we analyzed the cases of 842 consecutive patients between October 2006 and November 2011. Of these patients, we included 357 with a zero calcium score in the study. Information regarding patient age, sex, coronary risk factors, and symptom status were recorded. Coronary calcium-scoring scans were followed by CTCA. The calcium scores were calculated, and the presence of noncalcified plaques and significant stenoses (>50% of vessel diameter) was evaluated. RESULTS: Of the 357 patients with a zero calcium score, 37 (10.36%) had atherosclerotic plaques; 9 patients (2.52%) had significant coronary stenosis. Among coronary risk factors, only diabetes mellitus was significantly correlated with any risk factors (presence of atherosclerosis and obstructive coronary artery disease; P = .030 and .013, respectively). CONCLUSION: Although CAC scoring is a safe and a reliable test to exclude obstructive coronary artery disease, the absence of CAC does not definitively exclude the presence of atherosclerosis. CTCA is a more appropriate method for determining the atheroma burden.

Coexistence of Ankylosing Spondylitis and Klinefelter's Syndrome.

Ankylosing spondylitis is a chronic inflammatory disease characterized by inflammatory lower back pain and morning stiffness and accompanied by spine and sacroiliac joint involvement. Klinefelter's syndrome is a genetic condition that only affects males. Affected males have an extra X chromosome. This paper reports a 30-years-old male on followup with the diagnosis of Klinefelters syndrome. The patient admitted with complaints of inflammatory lower back, and neck pain and morning stiffness and was diagnosed with ankylosing spondylitis. Nonsteroidal anti-inflammatory drug and salazopyrine treatment resulted in significant regression in his complaints.

Sarcoidosis Presenting as Löfgren's Syndrome with Myopathy.

A 34-year-old female patient, who had proximal muscle weakness for 8 months, presented with erythema nodosum lesions on the pretibial region in addition to pain, swelling, and movement restriction in both ankles for the last one month. Thoracic CT demonstrated hilar and mediastinal lymphadenopathy. She underwent mediastinoscopic lymph node biopsy; biopsy result was consistent with noncaseating granuloma. Serum angiotensin converting enzyme level and muscle enzymes have been elevated. Muscular MRI and EMG findings were consistent with myositis. Muscle biopsy was done, and myopathy was found. The patient was diagnosed with sarcoidosis, Löfgren's syndrome, and sarcoid myopathy. The patient displayed remarkable clinical and radiological regression after 6-month corticosteroid and MTX therapy.

Clinically Occult Pituitary Adenoma Can Appear as a Hypermetabolic Lesion on Whole Body FDG PET Imaging in a Patient with Lymphoma.

UNLABELLED: We report a case with Non-Hodgkin Lymphoma with a focus of intense hypermetabolism in the sellar region in the primary staging and posttreatment whole body F-18 FDG PET. Further evaluation with magnetic resonance imaging after posttreatment FDG PET revealed a pituitary adenoma. Endocrinologic workup was normal consistent with nonfunctioning pituitary adenoma and endocrinologists decided to follow up the patient by yearly magnetic resonance imaging. This case demonstrates a nonfunctioning pituitary adenoma by whole body FDG PET and emphasizes the importance of pursuing incidental findings detected in the sella on PET imaging. CONFLICT OF INTEREST: None declared.

Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Diagnosis with CT Angiography.

Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital anomaly. It is associated with early infant mortality and sudden death in adults. Traditionally, ALCAPA has been diagnosed by angiography or autopsy; however, the development of cardiac computed tomography (CT) and magnetic resonance imaging (MRI) has allowed noninvasive evaluation of the coronary anatomy by direct visualization of the origin of the left coronary artery (LCA) from the pulmonary artery. We report a case of 10-year-old girl who has been on follow up for dilated cardiomyopathy for 4 years. The definitive diagnosis of ALCAPA is reached by multislice computed tomography (MSCT). The MSCT scan showed an anomalous origin of LCA from the pulmonary trunk, with a tortuous and dilated right coronary artery and right-to-left collateralization. Consequently, the patient was successfully treated with surgery.

A rare coronary artery anomaly: double left anterior descending artery.

Double left anterior descending coronary artery arising from the left and right coronary arteries is one of the rarest of coronary anomalies. In this report, we present a case of double left anterior descending coronary artery with one originating from the left main stem and the second one originating from the same ostium with the right coronary artery, passing to the left side following an inter-arterial course between aorta and right ventricular outflow tract and spreading to the anterior wall of the left ventricle. The diagnosis was made with multislice computed tomography angiography. To our knowledge, only a few such cases have been published in the literature so far.

The contribution of MR coronary angiography to the diagnosis of a left anterior descending artery aneurysm in a patient with Kawasaki disease.

We present a 4-year-old boy with a diagnosis of Kawasaki disease of six-month history. At the time of diagnosis, no significant coronary artery aneurysm was detected by transthoracic echocardiography. On his routine follow-up echocardiography, dilatation of the left anterior descending (LAD) artery was suspected, but an exact diagnosis could not be made. He underwent magnetic resonance (MR) coronary angiography which showed a large fusiform aneurysmatic dilatation in the proximal segment of the LAD with a diameter of 9 mm. Coronary angiography performed to plan surgical repair confirmed the findings of MR angiography. The patient's parents refused surgical repair, so antiplatelet therapy was started to prevent thrombosis. No complications occurred during seven months of follow-up after detection of the aneurysm.

Accuracy of MR coronary angiography in the evaluation of coronary artery stenosis.

PURPOSE: To examine the accuracy of magnetic resonance (MR) coronary angiography for the evaluation of coronary artery stenoses, and to compare the results with conventional angiography as the reference standard. MATERIALS AND METHODS: Eighteen patients were examined. The pulse sequence was an ECG-triggered, T2-prepared, fat-suppressed 3D true fast imaging with steady state precession sequence with navigator respiratory gating. No contrast material was used. The 3D slabs were oriented axially, covering the whole heart. The MR images were evaluated for the presence of stenoses exceeding 50% luminal narrowing. The diagnostic accuracy of MR angiography was calculated, and was compared with conventional coronary angiography. All patients gave informed consent, and the study was approved by the institutional ethics committee. RESULTS: In conventional angiography, 16 stenoses were detected in 11 patients, and 7 patients were normal. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of MR coronary angiography for detecting coronary stenosis on segment-based analysis were 75%, 98%, 80%, 97%, and 96%, respectively. McNemar test demonstrated no significant difference between MR and conventional angiography (P = 0.62). CONCLUSION: MR coronary angiography is a non-invasive diagnostic method currently in a state of evolution. It has limitations, but can be regarded as an alternative noninvasive modality to detect coronary artery disease in selected patient in whom invasive angiography may be hazardous.

Evaluation of coronary stent patency and in-stent restenosis with dual-source CT coronary angiography without heart rate control.

OBJECTIVE: Dual-source CT has excellent temporal resolution and allows good visualization of coronary vessels without heart rate control. Our aim was to evaluate the diagnostic performance of dual-source CT in the evaluation of coronary stent patency to determine whether the good temporal resolution would improve visualization of stents. SUBJECTS AND METHODS: Thirty-five consecutively registered patients (10 women, 25 men; mean age, 65 years) with 48 stents were examined prospectively without heart rate controlling agents. Observers evaluating image quality and patency of the stents were blinded to the results of invasive coronary angiography. In-stent restenosis was defined as more than 50% narrowing of the lumen. RESULTS: All stents were considered assessable for diagnosis with dual-source CT. In 85% (41/48) of the stents, image quality was good. Only two patent stents were misidentified as being stenotic. All other stents with stenosis and occlusion were correctly diagnosed. The sensitivity, specificity, positive and negative predictive values, and accuracy of dual-source CT in the detection of in-stent restenosis and occlusion were 100%, 94%, 89%, 100%, and 96%, respectively. The McNemar test result showed no statistically significant difference between the diagnostic performance of dual-source CT and that of invasive coronary angiography. The kappa indexes showed excellent intraobserver and interobserver agreement. CONCLUSION: The high temporal resolution of dual-source CT is helpful for evaluation of coronary stents without heart rate control. Further confirmation of our preliminary results may broaden the clinical indications for CT angiography as a diagnostic test for the exclusion of in-stent restenosis.

An aneurysmal left circumflex artery-to-right atrium fistula in a patient with ischemic symptoms: accurate diagnosis with dual-source CT angiography.

In this report, we present a 55-year-old female patient with a left circumflex artery-to-right atrial fistula associated with a huge saccular aneurysm. She had undergone conventional angiography due to ischemic symptoms. In conventional angiography, a very dilated and tortuous vessel originating from the circumflex artery and continuous with a huge saccular aneurysm was visualized but the drainage site could not be demonstrated. With dual-source CT coronary angiography, the exact anatomy of this fistula was demonstrated and surgery was planned.

Effectiveness of dual-source CT coronary angiography for the evaluation of coronary artery disease in patients with atrial fibrillation: initial experience.

PURPOSE: To prospectively evaluate the sensitivity and specificity of dual-source CT for significant coronary stenosis (>50% narrowing) in patients with atrial fibrillation (AF), by using conventional coronary angiography as the reference standard. MATERIALS AND METHODS: Institutional Review Board approval and informed consent were obtained. Fifteen consecutive patients (nine men, six women; mean age, 58.47 years) were examined. Image quality (good, moderate, or poor) and significant stenosis (>50%) were evaluated by two radiologists blinded to the conventional coronary angiography results. Sensitivity, specificity, positive predictive value (PPV), and negative predictive values (NPV) were calculated. McNemar test was used to search for any significant difference between dual-source CT and conventional coronary angiography in helping detect coronary stenosis. kappa statistics were calculated for intermodality and interobserver agreement. RESULTS: Sixteen segments by reader 1 and 13 segments by reader 2 were considered as poor image quality and rejected for further analysis. All segments with good image quality were correctly diagnosed. The respective overall sensitivity, specificity, PPV, and NPV values were 87%, 98%, 77%, and 99% for reader 1 and 80%, 99%, 80%, and 99% for reader 2. No significant difference between dual-source CT and conventional coronary angiography was found in helping detect significant stenosis. kappa statistics demonstrated good intermodality and excellent interobserver agreement. CONCLUSION: Dual-source CT technology provides a temporal resolution that allows CT coronary angiography at higher heart rates and even with AF.

Contrast-enhanced 64-slice computed tomography in detection and evaluation of anomalous coronary arteries.

Anomalous coronary artery (ACA) has either an unusual origin or different anatomical course and is associated with sudden cardiac death. The absence or nonspecific symptoms of ACA make its diagnosis difficult. Mostly, ACA is diagnosed coincidentally during invasive coronary angiogram (ICA). A conventional computed tomography (CT) cannot provide detailed images of coronary arteries of the moving heart, but 64-slice CT, with its short acquisition time, can provide detailed anatomy of coronary arteries non-invasively. In this study, we assessed the validity of contrast-enhanced 64-slice CT in the evaluation of ACA. ICA was performed in 7,574 patients for the diagnosis or evaluation of occlusive coronary artery disease and detected coronary anomalies in 56 patients (0.7%). We then performed 64-slice CT in 53 patients out of the 56 patients with demonstrated or suspected coronary anomaly, showing the origin and the course of the ACA along with stenosis, except for one patient who could not be evaluated due to image distortion artifacts. Contrast-enhanced 64-slice CT was also performed in 374 patients with vague signs and symptoms, detecting coronary anomalies in 7 patients (1.2%). Thus, in the total of 59 patients undergone 64-slice CT, we were able to visualize the entire abnormal coronary tree with a high diagnostic image quality. This is the first study to demonstrate the utility of 64-slice CT in a large series of ACA. Contrast-enhanced 64-slice CT is superior to ICA to identify the presence and course of ACA and should be the first line diagnostic tool in the evaluation of ACA.

Detection of significant coronary artery stenosis with 64-section MDCT angiography.

PURPOSE: To prospectively evaluate the diagnostic performance of 64-section multidetector computed tomography (MDCT) to detect significant coronary artery stenosis using conventional coronary angiography (CCA) as the reference standard. MATERIALS AND METHODS: Institutional Review Board approval and informed consent were obtained. In this prospective study, 80 patients (61 male, 19 female, mean age 56) were examined. Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) were calculated. McNemar test was used to search for the significant difference between 64-section MDCT angiography and CCA to detect stenosis. Also, kappa index (kappa) for the agreement between MDCT angiography and CCA was calculated. RESULTS: The sensitivity, specificity, positive (PPV) and negative predictive values (NPV) for detecting significant stenosis were 96%, 98%, 91%, 99%, respectively. The sensitivity, specificity, PPV and NPV for classification of patients with or without CAD were 100% for all. McNemar test demonstrated no significant difference between 64-section MDCT angiography and CCA. Also, kappa index (kappa) indicated excellent agreement. CONCLUSION: Sixty-four section MDCT angiography is an effective diagnostic tool for the detection of significant coronary artery stenosis. Especially, the potential to differentiate patients with and without CAD may provide MDCT an important role in the prevention of unnecessary invasive diagnostic procedures.